187 results on '"Hidaka, Isao"'
Search Results
2. Iron-rich Kupffer cells exhibit phenotypic changes during the development of liver fibrosis in NASH
3. Splenic non-infarction volume determines a clinically significant hepatic venous pressure gradient response to partial splenic embolization in patients with cirrhosis and hypersplenism
4. Microfluidic device for the high-throughput and selective encapsulation of single target cells
5. Usefulness of adult medaka fish as a model for the evaluation of alcoholic fatty liver
6. Lysosomal cholesterol overload in macrophages promotes liver fibrosis in a mouse model of NASH
7. Early Prediction of Response Focused on Tumor Markers in Atezolizumab plus Bevacizumab Therapy for Hepatocellular Carcinoma
8. Evaluation of the “assessment for continuous treatment with hepatic arterial infusion chemotherapy” scoring system in patients with advanced hepatocellular carcinoma
9. A novel noninvasive formula for predicting cirrhosis in patients with chronic hepatitis C
10. Promotion of intrahospital referral of hepatitis virus-positive patients to hepatology specialists through interprofessional collaboration, including clinical laboratory technicians
11. An autopsy case of primary malignant lymphoma of the spleen with acute liver failure and respiratory failure
12. Effect of transcatheter arterial infusion chemotherapy using iodized oil and degradable starch microspheres for hepatocellular carcinoma
13. Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy
14. Association of tyrosine with insulin resistance in hepatitis C virus-related chronic liver disease
15. Serum transferrin as a predictor of prognosis for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma
16. Albumin–bilirubin score as a useful predictor of energy malnutrition in patients with hepatocellular carcinoma
17. Short-term Effects of Hepatic Arterial Buffer Responses Induced by Partial Splenic Embolization on the Hepatic Function of Patients with Cirrhosis According to the Child-Pugh Classification
18. Cost-effectiveness of a “treat-all” strategy using Direct-Acting Antivirals (DAAs) for Japanese patients with chronic hepatitis C genotype 1 at different fibrosis stages
19. Rendezvous therapy with endoscopic and endovascular treatments for rectal arteriovenous malformation: A case report
20. Hepatitis C virus core protein inhibits deoxycholic acid-mediated apoptosis despite generating mitochondrial reactive oxygen species
21. In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C: correlation with hepatic steatosis
22. Clinical Benefits of Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma
23. Establishing Efficient Systems through Electronic Medical Records to Promote Intra-hospital Referrals of Hepatitis Virus Carriers to Hepatology Specialists: A Multicenter Questionnaire-based Survey of 1,281 Healthcare Professionals
24. Present status of hepatitis medical care coordinators in regional core centers in Japan
25. A glycyrrhizin-containing preparation reduces hepatic steatosis induced by hepatitis C virus protein and iron in mice
26. Effect of Handgrip Strength on Clinical Outcomes of Patients with Hepatocellular Carcinoma Treated with Lenvatinib
27. Evaluation of a symptom checklist for the early detection of symptoms in patients with chronic liver disease
28. Treatment of refractory oral lichen planus using direct antiviral agents in a patient with chronic hepatitis C: A case report
29. Early Predictors of Objective Response in Patients with Hepatocellular Carcinoma Undergoing Lenvatinib Treatment
30. Novel Liquid Biopsy Test Based on a Sensitive Methylated SEPT9 Assay for Diagnosing Hepatocellular Carcinoma
31. Hepatitis C virus protein and iron overload induce hepatic steatosis through the unfolded protein response in mice
32. Mitochondrial electron transport inhibition in full genomic hepatitis C virus replicon cells is restored by reducing viral replication
33. Stronger Neo-Minophagen C™, a glycyrrhizin-containing preparation, protects liver against carbon tetrachloride-induced oxidative stress in transgenic mice expressing the hepatitis C virus polyprotein
34. In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C: correlation with hepatic steatosis: APASL\Abstract\21
35. Novel Therapeutic Strategy Using Interventional Radiology (IVR) for Hepatitis C Virus (HCV)-Related Decompensated Liver Cirrhosis: A Case Report
36. A novel therapeutic strategy for esophageal varices using endoscopic treatment combined with splenic artery embolization according to the Child-Pugh classification
37. Effect of body composition on survival benefit of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: A comparison with sorafenib therapy
38. A case of chronic hepatitis c with charcot-marie-tooth disease successfully treated with interferon beta and rivabirin combination therapy
39. A case of ruptured hepatocellular carcinoma immediately after transcatheter arterial chemoembolization
40. Analysis of the safety of pretransplant corticosteroid therapy in patients with acute liver failure and late‐onset hepatic failure in Japan.
41. Analysis of tolvaptan non‐responders and outcomes of tolvaptan treatment of ascites
42. Treatment strategies for advanced hepatocellular carcinoma: Sorafenib vs hepatic arterial infusion chemotherapy
43. Liver stiffness measured by transient elastography as predictor of prognoses following portosystemic shunt occlusion
44. Comparison of patients with hepatic encephalopathy and those with gastric varices before and after balloon-occluded retrograde transvenous obliteration
45. Assessment of high fat diet-induced fatty liver in medaka
46. No Muscle Depletion with High Visceral Fat as a Novel Beneficial Biomarker of Sorafenib for Hepatocellular Carcinoma
47. Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study
48. Hemobilia immediately after transcatheter arterial chemoembolization using drug-eluting beads for hepatocellular carcinoma with intrahepatic bile duct invasion
49. CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis
50. Evaluation of the “assessment for continuous treatment with hepatic arterial infusion chemotherapy” scoring system in patients with advanced hepatocellular carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.